Research and Markets: The World Pufas Market: A Review of Scientific Studies as Well as Profile of Using Companies

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/b86f4f/the_world_pufas_ma) has announced the addition of the "The World Pufas Market" report to their offering.

This global study analyzes the Pufas market through a review of scientific studies as well as profile of using companies describing their needs, their technical issues and expectations towards those ingredients.

Fatty acids have several biological functions in the organism. They provide energy, they form part of the membranes surrounding cells. Besides, they are precursors of some specific chemical messengers known as prostaglandines, tromboxanes and leucotrienes. These chemical messengers control an important number of biochemical reactions, that include growth, cell division, blood pressure, blood coagulation, immune reactions and tissue inflammation. It is also now widely recognized that LC-PUFAs play an important role in infant development and the maintenance of health in mature human beings.

This global study analyzes the Pufas market through a review of scientific studies as well as profile of using companies describing their needs, their technical issues and expectations towards those ingredients.

Key Topics Covered:

A)INTRODUCTION

B) HEALTH PROPERTIES

1 - Omega-6 fatty acids

2 - Problems encountered with LC-PUFAs

3 - Omega-6 fatty acids Description

4 - Omega-3 / omega-6 balance

5 - Process Extraction and concentration process by physical and chemical pathways :Biochemical process

C) REGULATION

6 - KEY MARKET ISSUES

D) SUPPLIERS

Companies mentioned:

  • BASF (DK)
  • DENOMEGA (NW)
  • DSM (NL)
  • LODERS CROKLAAN (NL)
  • CARGILL (G)
  • MARTEK BIOSCIENCES CORP.(USA)
  • OMEGA PROTEIN INC.(USA)
  • PRONOVA (NW)
  • SOLAE (USA)
  • AURORA ALGAE (USA)
  • CRODA (UK)
  • EPAX (NO)
  • MARINE NUTRICEUTICAL (USA)
  • OCEAN NUTRITION (CA)

For more information visit http://www.researchandmarkets.com/research/b86f4f/the_world_pufas_ma.



CONTACT:

Research and Markets
Laura Wood, Senior Manager
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:   United States  Europe  Asia Pacific  North America

INDUSTRY KEYWORDS:   Health  Biotechnology  Cardiology  Professional Services  Other Professional Services

MEDIA:

Logo
 Logo

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.